Department of Endocrinology and Metabolism, People's Hospital of Zhengzhou Affiliated Henan University of Chinese Medicine, Zhengzhou, China.
Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
J Diabetes. 2022 May;14(5):345-355. doi: 10.1111/1753-0407.13269. Epub 2022 May 5.
To investigate the arterial stiffness (AS) risk within urinary albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR) categories and the joint effect between kidney disease parameters and metabolic goal achievement on AS risk in adult people with type 2 diabetes (T2D).
A total of 27 439 Chinese participants with T2D from 10 National Metabolic Management Centers (MMC) were categorized into four albuminuria/decreased eGFR groups. The criteria for decreased eGFR and AS were eGFR <90 ml/min/1.73 m and brachial-ankle pulse wave velocity value >the 75th percentile (1770.0 cm/s). Three metabolic goals were defined as glycated hemoglobin <7%, BP <130/80 mmHg, andlow-density lipoprotein cholesterol <2.6 mmol/L.
After full adjustment, odds ratios (ORs) for AS were highest for albuminuria and decreased eGFR (2.23 [1.98-2.52]) and were higher for albuminuria and normal eGFR (1.52 [1.39-1.67]) than for those with nonalbuminuria and decreased eGFR (1.17 [1.04-1.32]). Both UACR and eGFR in the subgroup or overall population independently correlated with AS risk. The achievement of ≥2 metabolic goals counteracted the association between albuminuria and AS risk (OR: 0.93; 95% CI: 0.80-1.07; p = .311). When the metabolic goals added up to ≥2 for patients with decreased eGFR, they showed significantly lower AS risk (OR: 0.65; 95% CI: 0.56-0.74; p < .001).
Both higher UACR and lower eGFR are determinants of AS risk, with UACR more strongly related to AS than eGFR in adults with T2D. The correlation between albuminuria/decreased eGFR and AS was modified by the achievement of multiple metabolic elements.
本研究旨在探讨 2 型糖尿病(T2D)患者中尿白蛋白/肌酐比值(UACR)和估计肾小球滤过率(eGFR)范围内的动脉僵硬度(AS)风险,以及肾脏疾病参数与代谢目标达标情况对 AS 风险的联合影响。
本研究共纳入来自 10 个国家代谢管理中心(MMC)的 27439 例中国 T2D 患者,将其分为 4 组白蛋白尿/降低 eGFR 组。降低 eGFR 和 AS 的标准为 eGFR <90ml/min/1.73m 和肱踝脉搏波速度值>第 75 百分位数(1770.0cm/s)。定义了 3 项代谢目标,即糖化血红蛋白<7%、血压<130/80mmHg 和低密度脂蛋白胆固醇<2.6mmol/L。
在充分调整后,与非白蛋白尿/降低 eGFR 相比,白蛋白尿和降低 eGFR(2.23[1.98-2.52])及白蛋白尿和正常 eGFR(1.52[1.39-1.67])的 AS 比值比(OR)最高。在亚组或总体人群中,UACR 和 eGFR 均与 AS 风险独立相关。≥2 项代谢目标的达标情况可以拮抗白蛋白尿与 AS 风险之间的关系(OR:0.93;95%CI:0.80-1.07;p=0.311)。当降低 eGFR 的患者达到≥2 项代谢目标时,其 AS 风险显著降低(OR:0.65;95%CI:0.56-0.74;p<0.001)。
较高的 UACR 和较低的 eGFR 都是 AS 风险的决定因素,在 T2D 患者中,UACR 与 AS 的相关性强于 eGFR。白蛋白尿/降低 eGFR 与 AS 之间的相关性受多种代谢因素达标情况的影响。